Skip to main content
Fig. 8 | BMC Infectious Diseases

Fig. 8

From: TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients

Fig. 8

Combination of TLR9 1635AA-1486CC genotype is associated with lower CD4 counts, higher T cell immune activation and elevated IP10 levels in HIV infected patients. TLR9 1635 and 1486 polymorphisms were determined by PCR-RFLP analysis. Data was stratified based on both the 1635 and 1486 genotypes for each patient. Association of TLR9 1635 and 1486 genotype with (a) CD4 counts (b) CD8 immune activation and (c) plasma IP10 levels in HIV infected individuals is shown. Kruskal-Wallis test was used for statistical analysis (** p < 0.005)

Back to article page